Document is current
Any future updates will be listed below
-
Authors
Ebrahim, Nour
Kondratyev, Nikolay
Artyuhov, Alexander
Timofeev, Alexei
Gurskaya, Nadya
Andrianov, Alexey
Izrailov, Roman
Volchkov, Egor
Dyuzheva, Tatyana
Kopantseva, Elena
Kiseleva, Ekaterina
Golimbet, Vera
Dashinimaev, Erdem https://orcid.org/0000-0002-5640-7139
-
Funding
Funding for this research was provided by:
Ministry of Science and Higher Education of the Russian Federation (075-15-2019-1789)
- License Information
-
More Information
Article History
Received: 16 August 2024
Accepted: 26 September 2024
First Online: 8 October 2024
Declarations
:
: The human pancreatic tail specimens were taken by incision biopsy after distal pancreatectomy or laparoscopic pancreatoduodenectomy in five patients (age ≥ 45 yr, M:F = 3:2) diagnosed with pancreatic cancer. This part of the study was conducted in accordance with the Declaration of Helsinki and the legislation of the Russian Federation on human health protection. The use of biopsied tissue for scientific purposes was approved by the Ethical Board at the Loginov Moscow Clinical Scientific Center (Board Record #1/2020 of February 3, 2020), title of the approved project “Development of technology for reprogramming stromal cells for the treatment of type 1 diabetes”. All patients provided written informed consent for biospecimen donation and signed a special agreement for participation in scientific research.
: The authors declare no conflict of interest. The funders had no role in the design of the study, in the collection, analysis, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.
